Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)

NCT00764478 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

367

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar 1 Disorder

Interventions

DRUG: Asenapine
DRUG: Asenapine
DRUG: Placebo

Sponsor

Organon and Co